help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on November 3, 2003, doi:10.1164/rccm.200305-619OC

Am. J. Respir. Crit. Care Med., Volume 169, Number 3, February 2004, 399-406

A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200305-619OCv1
169/3/399    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, L. J
Right arrow Articles by Shute, J. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, L. J
Right arrow Articles by Shute, J. K

Submitted on May 7, 2003
Accepted on October 27, 2003

Free secretory component from cystic fibrosis sputa displays the CF glycosylation phenotype

Lindsay J Marshall1*, Beatrice Perks1, Kathleen Bodey1, Ranjan Suri2, Andrew Bush2, and Janis K Shute1

1 School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom, 2 Respiratory Paediatrics, Royal Brompton Hospital, London, United Kingdom

* To whom correspondence should be addressed. E-mail: Lindsay.Marshall{at}port.ac.uk.

Secretory IgA contributes to humoral defence mechanisms against pathogens targeting mucosal surfaces, and secretory component fulfils multiple roles in this defence. The aims of this study were to quantify total secretory component and to analyse the form of free secretory component in sputa from normal, asthmatic and cystic fibrosis subjects. Significantly higher levels of secretory component were detected in cystic fibrosis compared to both other groups. Gel filtration chromatography revealed that secretory component in cystic fibrosis was relatively degraded. Free secretory component normally binds interleukin-8 and inhibits its function. However, in cystic fibrosis sputa, interleukin-8 binding to intact secretory component was reduced. Analysis of the total carbohydrate content of free secretory component signified over-glycosylation in cystic fibrosis compared to normal and asthmatic subjects. Monosaccharide composition analysis of free secretory component from cystic fibrosis subjects revealed over-fucosylation and under-sialylation, in agreement with the reported cystic fibrosis glycosylation phenotype. Secretory component binding to interleukin-8 did not interfere with the binding of interleukin-8 to heparin, indicating distinct binding sites on interleukin-8 for negative regulation of function by secretory component and heparin. We suggest that defective structure and function of secretory component contributes to the characteristic sustained inflammatory response in the cystic fibrosis airways.


Key words: polymeric immunoglobulin receptor, glycoproteins, inflammation, respiratory mucosa




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush, F. Accurso, W. MacNee, S. C. Lazarus, and E. Abraham
Cystic Fibrosis, Pediatrics, Control of Breathing, Pulmonary Physiology and Anatomy, and Surfactant Biology in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 545 - 553.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  ATS State of the Art 2009